Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Relationship-building at Top of Mind for Clients

August 2, 2014

Pharmaceutical Technology

Annual study shows CMO technical expertise is not enough.

Pharma Investments Reflect Key Industry Trends

August 2, 2014

Pharmaceutical Technology

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Positive Outlook for Outsourcing

August 1, 2014

Pharmaceutical Technology

Contract services ride high as funding floods bio/pharma.

Weighing Clinical Trial Outsourcing Options

August 1, 2014

Pharmaceutical Technology

Evolving clinical trial research services give biopharmaceutical companies options for full and functional services.

Quality by Design in Contract Service Relationships

August 1, 2014
Pharmaceutical Technology

Contract service providers describe how quality by design has influenced a drug sponsor's expectations of suppliers.

Europe's Need for Early Development Pharmaceutical Manufacturing Expertise

August 1, 2014

Pharmaceutical Technology

Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.

Outsourcing Grows in Europe

August 1, 2014

Pharmaceutical Technology Europe

Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years.

Solid-Dosage Forms Demand Traditional and Emerging Technologies

August 1, 2014
Pharmaceutical Technology

Contract development and manufacturing organizations identify trends, challenges, and emerging technology and service needs for solid and semi-solid dosage forms.

Contractors Invest in Capacity and Capabilities

August 1, 2014
Pharmaceutical Technology

Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here